Logo image of ENFN

ENFUSION INC - CLASS A (ENFN) Stock Fundamental Analysis

NYSE:ENFN - New York Stock Exchange, Inc. - US2928121043 - Common Stock - Currency: USD

10.76  -0.04 (-0.37%)

After market: 10.76 0 (0%)

Fundamental Rating

6

Taking everything into account, ENFN scores 6 out of 10 in our fundamental rating. ENFN was compared to 284 industry peers in the Software industry. ENFN has an excellent financial health rating, but there are some minor concerns on its profitability. ENFN is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ENFN had positive earnings in the past year.
In the past year ENFN had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ENFN reported negative net income in multiple years.
ENFN had a positive operating cash flow in 4 of the past 5 years.
ENFN Yearly Net Income VS EBIT VS OCF VS FCFENFN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -100M -200M

1.2 Ratios

With a decent Return On Assets value of 1.97%, ENFN is doing good in the industry, outperforming 67.61% of the companies in the same industry.
ENFN's Return On Equity of 3.86% is fine compared to the rest of the industry. ENFN outperforms 68.66% of its industry peers.
ENFN's Return On Invested Capital of 3.55% is fine compared to the rest of the industry. ENFN outperforms 73.24% of its industry peers.
Industry RankSector Rank
ROA 1.97%
ROE 3.86%
ROIC 3.55%
ROA(3y)0.28%
ROA(5y)-33.14%
ROE(3y)0.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ENFN Yearly ROA, ROE, ROICENFN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

The Profit Margin of ENFN (1.40%) is better than 65.14% of its industry peers.
In the last couple of years the Profit Margin of ENFN has declined.
With a decent Operating Margin value of 3.05%, ENFN is doing good in the industry, outperforming 68.66% of the companies in the same industry.
ENFN's Operating Margin has declined in the last couple of years.
The Gross Margin of ENFN (67.82%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of ENFN has remained more or less at the same level.
Industry RankSector Rank
OM 3.05%
PM (TTM) 1.4%
GM 67.82%
OM growth 3YN/A
OM growth 5Y-33.55%
PM growth 3YN/A
PM growth 5Y-42.1%
GM growth 3Y-1.76%
GM growth 5Y-1.01%
ENFN Yearly Profit, Operating, Gross MarginsENFN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -100 -200

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ENFN is destroying value.
ENFN has more shares outstanding than it did 1 year ago.
The number of shares outstanding for ENFN has been increased compared to 5 years ago.
There is no outstanding debt for ENFN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ENFN Yearly Shares OutstandingENFN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ENFN Yearly Total Debt VS Total AssetsENFN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M

2.2 Solvency

An Altman-Z score of 12.41 indicates that ENFN is not in any danger for bankruptcy at the moment.
ENFN has a Altman-Z score of 12.41. This is amongst the best in the industry. ENFN outperforms 90.49% of its industry peers.
There is no outstanding debt for ENFN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 12.41
ROIC/WACC0.32
WACC11%
ENFN Yearly LT Debt VS Equity VS FCFENFN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

ENFN has a Current Ratio of 3.42. This indicates that ENFN is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.42, ENFN is in the better half of the industry, outperforming 76.76% of the companies in the same industry.
ENFN has a Quick Ratio of 3.42. This indicates that ENFN is financially healthy and has no problem in meeting its short term obligations.
ENFN has a Quick ratio of 3.42. This is in the better half of the industry: ENFN outperforms 76.76% of its industry peers.
Industry RankSector Rank
Current Ratio 3.42
Quick Ratio 3.42
ENFN Yearly Current Assets VS Current LiabilitesENFN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 35.71% over the past year.
ENFN shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -22.78% yearly.
ENFN shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.51%.
Measured over the past years, ENFN shows a very strong growth in Revenue. The Revenue has been growing by 27.86% on average per year.
EPS 1Y (TTM)35.71%
EPS 3YN/A
EPS 5Y-22.78%
EPS Q2Q%-25%
Revenue 1Y (TTM)15.51%
Revenue growth 3Y21.76%
Revenue growth 5Y27.86%
Sales Q2Q%13.88%

3.2 Future

ENFN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 27.93% yearly.
The Revenue is expected to grow by 15.45% on average over the next years. This is quite good.
EPS Next Y50.32%
EPS Next 2Y40.46%
EPS Next 3Y27.93%
EPS Next 5YN/A
Revenue Next Year16.39%
Revenue Next 2Y16.32%
Revenue Next 3Y15.45%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ENFN Yearly Revenue VS EstimatesENFN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
ENFN Yearly EPS VS EstimatesENFN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 56.63, which means the current valuation is very expensive for ENFN.
ENFN's Price/Earnings ratio is in line with the industry average.
ENFN's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.55.
With a Price/Forward Earnings ratio of 37.68, ENFN can be considered very expensive at the moment.
ENFN's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ENFN is cheaper than 60.56% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.30, ENFN is valued quite expensively.
Industry RankSector Rank
PE 56.63
Fwd PE 37.68
ENFN Price Earnings VS Forward Price EarningsENFN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

61.97% of the companies in the same industry are more expensive than ENFN, based on the Enterprise Value to EBITDA ratio.
The rest of the industry has a similar Price/Free Cash Flow ratio as ENFN.
Industry RankSector Rank
P/FCF 58.73
EV/EBITDA 74.97
ENFN Per share dataENFN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

ENFN's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as ENFN's earnings are expected to grow with 27.93% in the coming years.
PEG (NY)1.13
PEG (5Y)N/A
EPS Next 2Y40.46%
EPS Next 3Y27.93%

0

5. Dividend

5.1 Amount

ENFN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENFUSION INC - CLASS A

NYSE:ENFN (4/17/2025, 8:15:24 PM)

After market: 10.76 0 (0%)

10.76

-0.04 (-0.37%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)03-03 2025-03-03/amc
Earnings (Next)05-08 2025-05-08/bmo
Inst Owners94.22%
Inst Owner Change6.76%
Ins Owners3.2%
Ins Owner Change-109.93%
Market Cap1.40B
Analysts50.91
Price Target11.15 (3.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-26.01%
Min EPS beat(2)-52.94%
Max EPS beat(2)0.93%
EPS beat(4)2
Avg EPS beat(4)-0.65%
Min EPS beat(4)-52.94%
Max EPS beat(4)62.27%
EPS beat(8)2
Avg EPS beat(8)-9.58%
EPS beat(12)5
Avg EPS beat(12)0.54%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.8%
Min Revenue beat(2)-4.7%
Max Revenue beat(2)-2.9%
Revenue beat(4)0
Avg Revenue beat(4)-2.95%
Min Revenue beat(4)-4.7%
Max Revenue beat(4)-1.06%
Revenue beat(8)1
Avg Revenue beat(8)-2.79%
Revenue beat(12)3
Avg Revenue beat(12)-1.79%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.03%
PT rev (3m)7.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-10.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.45%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.51%
Revenue NY rev (1m)-0.6%
Revenue NY rev (3m)-0.73%
Valuation
Industry RankSector Rank
PE 56.63
Fwd PE 37.68
P/S 6.93
P/FCF 58.73
P/OCF 40.29
P/B 19.08
P/tB 19.08
EV/EBITDA 74.97
EPS(TTM)0.19
EY1.77%
EPS(NY)0.29
Fwd EY2.65%
FCF(TTM)0.18
FCFY1.7%
OCF(TTM)0.27
OCFY2.48%
SpS1.55
BVpS0.56
TBVpS0.56
PEG (NY)1.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.97%
ROE 3.86%
ROCE 5.31%
ROIC 3.55%
ROICexc 6.69%
ROICexgc 6.69%
OM 3.05%
PM (TTM) 1.4%
GM 67.82%
FCFM 11.8%
ROA(3y)0.28%
ROA(5y)-33.14%
ROE(3y)0.81%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-41.88%
ROICexc growth 3YN/A
ROICexc growth 5Y-41.88%
OM growth 3YN/A
OM growth 5Y-33.55%
PM growth 3YN/A
PM growth 5Y-42.1%
GM growth 3Y-1.76%
GM growth 5Y-1.01%
F-Score5
Asset Turnover1.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 92.67%
Cap/Sales 5.4%
Interest Coverage 250
Cash Conversion 193.66%
Profit Quality 842.72%
Current Ratio 3.42
Quick Ratio 3.42
Altman-Z 12.41
F-Score5
WACC11%
ROIC/WACC0.32
Cap/Depr(3y)104.86%
Cap/Depr(5y)147.45%
Cap/Sales(3y)5.41%
Cap/Sales(5y)5.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)35.71%
EPS 3YN/A
EPS 5Y-22.78%
EPS Q2Q%-25%
EPS Next Y50.32%
EPS Next 2Y40.46%
EPS Next 3Y27.93%
EPS Next 5YN/A
Revenue 1Y (TTM)15.51%
Revenue growth 3Y21.76%
Revenue growth 5Y27.86%
Sales Q2Q%13.88%
Revenue Next Year16.39%
Revenue Next 2Y16.32%
Revenue Next 3Y15.45%
Revenue Next 5YN/A
EBIT growth 1Y-48.51%
EBIT growth 3YN/A
EBIT growth 5Y-15.03%
EBIT Next Year76.73%
EBIT Next 3Y40.41%
EBIT Next 5YN/A
FCF growth 1Y49.03%
FCF growth 3YN/A
FCF growth 5Y24.73%
OCF growth 1Y35.3%
OCF growth 3YN/A
OCF growth 5Y23.02%